Improvement of Dissolution Rate of Gliclazide Using Solid Dispersions with Aerosil 380 and Its Effect on Alloxan Induced Diabetic Rats — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Improvement of Dissolution Rate of Gliclazide Using Solid Dispersions with Aerosil 380 and Its Effect on Alloxan Induced Diabetic Rats
Department of Pharmacy, Faculty of Science, Rajshahi University, Rajshahi, Bangladesh
,
Department of Pharmacy, Faculty of Science, Rajshahi University, Rajshahi, Bangladesh
,
Department of Pharmacy, Faculty of Life Science, Mawlana Bhashani Science and Technology University, Tangail, Bangladesh
,
Department of Pharmacy, Faculty of Science, Rajshahi University, Rajshahi, Bangladesh
,
Department of Pharmacy, Faculty of Science, Rajshahi University, Rajshahi, Bangladesh
,
Department of Pharmacy, Faculty of Science, Rajshahi University, Rajshahi, Bangladesh
1 Department of Pharmacy, Faculty of Science, Rajshahi University, Rajshahi, Bangladesh
2 Department of Pharmacy, Faculty of Science, Rajshahi University, Rajshahi, Bangladesh
3 Department of Pharmacy, Faculty of Life Science, Mawlana Bhashani Science and Technology University, Tangail, Bangladesh
4 Department of Pharmacy, Faculty of Science, Rajshahi University, Rajshahi, Bangladesh
5 Department of Pharmacy, Faculty of Science, Rajshahi University, Rajshahi, Bangladesh
6 Department of Pharmacy, Faculty of Science, Rajshahi University, Rajshahi, Bangladesh
The main objective of this research is to conduct a comprehensive study for enhancing the aqueous solubility of poorly water soluble gliclazide using hydrophilic fumed silica particles (Aerosil ® 380) and evaluating the influence of silica on drug release profile and pharmacological activity on alloxan induced diabetic rat s . Solid dispersions (SD’s) of gliclazide were prepared using solvent evaporation method. The dissolution profiles and solid state characterization of the SD’s prepared were all evaluated. The dissolution rate of gliclazide in the SD’s with fumed silica (weight ratio, 1:1) was approximately 38%, which is about 10 fold higher than that of the pure drug after 30 min. After forming the SD’s, gliclazide changed into an amorphous state, which can infer from differential scanning calorimetry (DSC) and powder X-ray diffraction (PXRD). Fourier transform infrared spectroscopy (FTIR) also revealed the formation of weak hydrogen bonding through the interactions between the secondary amine groups of gliclazide and silanol groups of silica particles in the SD’s. The rapid dissolution rate from the SD’s might be attributed to the amorphization of drug, improved specific surface area and wettability than the original drug crystals. Further, we investigated the antidiabetic effects of SD’s of gliclazide in alloxan induced diabetic rats. The SD’s of gliclazide decrease the blood glucose level 64% whereas the conventional gliclazide decreases only 37% in diabetic rat s . Lipid profiles, kidney and liver functions are remarkably improved in diabetic rat treated with SD’s of gliclazide than that of conventional gliclazide. These results suggest that SD’s of gliclazide have much more bioavailability and hence are more pharmacologically active than that of conventional gliclazide form.
Dressman, J.B., Amidon, G. L., Reppas, C. and Shah, V.P. (1998) Dissolution Testing as a Prognostic Tool for Oral Drug Absorption: Immediate Release Dosage Forms. Pharmaceutical Research, 15, 11-22. https://doi.org/10.1023/A:1011984216775
Amidon, G.L., Lennernäs, H., Shah, V.P. and Crison, J.R. (1995) A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability. Pharmaceutical Research, 12, 413-420. https://doi.org/10.1023/A:1016212804288
Löbenberg, R. and Amidon, G.L. (2000) Modern Bioavailability, Bioequivalence and Biopharmaceutics Classification System. New Scientific Approach to International Regulatory Standards. European Journal of Pharmaceutics and Biopharmaceutics, 50, 3-12. https://doi.org/10.1016/S0939-6411(00)00091-6
Alkhamis, K.A., Allaboun, H. and Al-Momani, W.Y. (2003) Study of the Solubilization of Gliclazide by Aqueous Micellar Solutions. Journal of Pharmaceutical Sciences, 92, 839-846. https://doi.org/10.1002/jps.10350
Varshosaz, J., Talari, R., Mostafavi, S.A. and Nokhodchi, A. (2008) Dissolution Enhancement of Gliclazide Using in Situ Micronization by Solvent Change Method. Powder Technology, 187, 222-230.
Saharan, V.A. and Choudhury, P.K. (2011) Dissolution Rate Enhancement of Gliclazide by Ordered Mixing. Acta Pharmaceutica, 61, 323-334. https://doi.org/10.2478/v10007-011-0021-7
Palmer, K.J. and Brogden, R.N. (1993) Gliclazide: An Update of Its Pharmacological Properties and Therapeutic Efficacy in Non-Insulin-Dependent Diabetes-Mellitus. Drugs, 46, 92-125. https://doi.org/10.2165/00003495-199346010-00007
Varma, M.M. and Kumar, P.S. (2012) Formulation and Evaluation of Gliclazide Tablets Containing PVP-K30 and Hydroxypropyl-Β-Cyclodextrin Solid Dispersions. International Journal of Pharmaceutical Sciences and Nanotechnology, 5, 1706-1719.
Sambath, L., Mathu, A.K., Kumar, M.A., Phaneendra, K. and Shalini (2013) Physicochemical Characterization and in Vitro Dissolution Behavior of Gliclazide -Soluplus Solid Dispersions. International Journal of Pharmacy and Pharmaceutical Sciences, 5, 204-210.
Patil, M.P. and Gaikwad, N.J. (2009) Preparation and Characterization of Gliclazide—Polyethylene Glycol 4000 Solid Dispersions. Acta Pharmaceutica, 59, 57-65.
Khattab, I.S., Nada, A. and Zaghloul, A.A. (2010) Physicochemical Characterization of Gliclazide-Macrogol Solid Dispersion and Tablets Based on Optimized Dispersion. Drug Development and Industrial Pharmacy, 36, 893-902. https://doi.org/10.3109/03639040903578734
Patil, M.P. and Gaikwad, N.J. (2011) Characterization of Gliclazide-Polyethylene Glycol Solid Dispersion and Its Effect on Dissolution. Brazilian Journal of Pharmaceutical Sciences, 47, 161-166.
Hosmani, A.H. and Thorat, Y.S. (2011) Optimization and Pharmacodynamic Evaluation of Solid Dispersion of Gliclazide for Dissolution Rate Enhancement. Latin American Journal of Pharmacy, 30, 1590-1595.
Barzegar-Jalali, M., Valizadeh, H., Shadbad, M.R.S., Adibkia, K., Mohammadi, G., Farahani, A., Arash, Z. and Nokhodchi, A. (2010) Cogrinding as an Approach to Enhance Dissolution Rate of a Poorly Water-Soluble Drug (Gliclazide). Powder Technology, 197, 150-158. https://doi.org/10.1016/j.powtec.2009.09.008
Biswal, S., Sahoo, J., Murthy, P.N., Giradkar, R.P. and Avari, J.G. (2008) Enhancement of Dissolution Rate of Gliclazide using Solid Dispersions with Polyethylene Glycol 6000. AAPS Pharmaceutical Science and Technology, 9, 563-570. https://doi.org/10.1208/s12249-008-9079-z
Sudarsan, B., Gouri, S.P., Jagannath, S. and Padala, N.M. (2009) An Approach for Improvement of the Dissolution Rate of Gliclazide. Dissolution Technologies. https://doi.org/10.14227/DT160409P15
Talari, R., Varshosaz, J., Mostafavi, S.A. and Nokhodchi, A. (2009) Dissolution Enhancement of Gliclazide using pH Change Approach in Presence of Twelve Stabilizers with Various Physicochemical Properties. Journal of Pharmacy and Pharmaceutical Science, 12, 250-265. https://doi.org/10.18433/J31P4P
Dina, E. and Imad I.H. (2014) Improvement of Dissolution Rate of Gliclazide Through Sodium Salt Formation. Dissolution Technologies. https://doi.org/10.14227/DT210414P49
Hu, J., Rogers, T.L., Brown, J., Young, T., Johnston, K.P. and Williams Iii, R.O. (2002) Improvement of Dissolution Rates of Poorly Water Soluble APIs using Novel Spray Freezing into Liquid Technology. Pharmaceutical Research, 19, 1278-1284. https://doi.org/10.1023/A:1020390422785
Mellaerts, R., Aerts, C.A., Van Humbeeck, J., Augustijns, P., Van den Mooter, G. and Martens, J.A. (2007) Enhanced Release of Itraconazole from Ordered Mesoporous SBA-15 Silica Materials. Chemical Communication, No. 13, 1375-1377. https://doi.org/10.1039/b616746b
Friedrich, H., Fussnegger, B., Kolter, K. and Bodmeier, R. (2006) Dissolution Rate Improvement of Poorly Water-Soluble Drugs Obtained by Adsorbing Solutions of Drugs in Hydrophilic Solvents onto High Surface Area Carriers. European Journal of Pharmaceutics and Biopharmaceutics, 62, 171-177. https://doi.org/10.1016/j.ejpb.2005.08.013
Horcajada, P., Ramila, A., Perez-Pariente, J. and Vallet-Regi, M. (2004) Influence of Pore Size of MCM-41 Matrices on Drug Delivery Rate. Microporous and Mesoporous Materials, 68, 105-109. https://doi.org/10.1016/j.micromeso.2003.12.012
Sanaa, A., El-Gizawy, S.A., Mohamed, A., Osman, M.F., Arafa, G.M. and El-Maghraby, G.M. (2015) Aerosil as a Novel Co-Crystal Co-Former for Improving the Dissolution Rate of Hydrochlorothiazide. International Journal of Pharmaceutics, 478, 773-778. https://doi.org/10.1016/j.ijpharm.2014.12.037
Angelos, S., Liong, M., Choi, E. and Zink, J.I. (2008) Mesoporous Silicate Materials as Substrates for Molecular Machines and Drug Delivery. Chemical Engineering Journal, 137, 4-13. https://doi.org/10.1016/j.cej.2007.07.074
Wang, S. (2009) Ordered Mesoporous Materials for Drug Delivery. Microporous and Mesoporous Materials, 117, 1-9. https://doi.org/10.1016/j.micromeso.2008.07.002
Wang, L., Cui, F.D. and Sunada, H. (2006) Preparation and Evaluation of Solid Dispersions of Nitrendipine Prepared with Fine Silica Particles Using the Melt-Mixing Method. Chemical and Pharmaceutical Bulletin, 54, 37-43.
Takeuchi, H., Handa, T. and Kawashima, Y. (1987) Spherical Solid Dispersion Containing Amorphous Tolbutamide Embedded in Enteric Coating Polymers or Colloidal Silica Prepared by Spray-Drying Technique. Chemical and Pharmaceutical Bulletin, 35, 3800-3806.
Takeuchi, H., Nagira, S., Yamamoto, H. and Kawashima, Y. (2003) Design of Solid Dispersion Particles of Drug with Fine Porous Carriers. Journal of the Society of Powder Technology, Japan, 40, 157-162.
Takeuchi, H., Nagira, S., Yamamoto, H. and Kawashima, Y. (2004) Solid Dispersion Particles of Tolbutamide Prepared with Fine Silica Particles by The Spray-Drying Method. Powder Technology, 141, 187-195. https://doi.org/10.1016/j.powtec.2004.03.007
Takeuchi, H., Nagira, S., Yamamoto, H. and Kawashima, Y. (2005) Solid Dispersion Particle of Amorphous Indomethacin with Fine Porous Silica Particle by Using Spray-Drying Method. International Journal of Pharmaceutics, 293, 155-164. https://doi.org/10.1016/j.ijpharm.2004.12.019
Watanabe, T., Wakiyama, N., Usui, F., Ikeda, M., Isobe, T. and Senna M. (2001) Stability of Amorphous Indomethacin Compounded with Silica. International Journal of Pharmaceutics, 226, 81-91. https://doi.org/10.1016/S0378-5173(01)00776-1
Watanabe, T., Ohno, I., Wakiyama, N., Kusai, A. and Senna, M. (2002) Controlled Dissolution Properties of Indomethacin by Compounding with Silica. STP Pharma Sciences, 12, 363-367.
Watanabe, T., Hasegawa, S., Wakiyama, N., Kusai, A. and Senna, M. (2003) Comparison between Polyvinylpyrrolidone and Silica Nanoparticles as Carriers for Indomethacin in a Solid State Dispersion. International Journal of Pharmaceutics, 250, 283-286. https://doi.org/10.1016/S0378-5173(02)00549-5
Matsumoto, K., Nakai, Y., Yonemochi, E., Oguchi, T. and Yamamoto, K. (1994) Physicochemical Characteristics of Porous Crystalline Cellulose and Formation of an Amorphous State of Ethenzamide by Mixing. International Journal of Pharmaceutics, 108, 167-172. https://doi.org/10.1016/0378-5173(94)90125-2
Nakai, Y., Yamamoto, K., Terada, K. and Ichikawa, J. (1984) Interaction of Medicinal and Porous Powder. I. Anomalous Thermal Behavior of Porous Glass Mixture. Chemical and Pharmaceutical Bulletin, 32, 4566-4571.
Matsumoto, K., Nakai, Y., Yonemochi, E., Oguchi, T. and Yamamoto, K. (1998) Effect of Pore Size on the Gaseous Adsorption of Ethenzamide on Porous Crystalline Cellulose and the Physicochemical Stability of Ethenzamide after Storage. Chemical and Pharmaceutical Bulletin, 46, 314-318.
Kinoshita, M., Baba, K., Nagayasu, A., Yamabe, K., Shimooka, T., Takeuchi, Y., Azuma, M., Houchi, H. and Minakuchi, K. (2002) Improvement of Solubility and Oral Bioavailability of a Poorly Water Soluble Drug, TAS-301, by It’s Melt Adsorption on a Porous Calcium Silicate. Journal of Pharmaceutical Sciences, 91, 362-370. https://doi.org/10.1002/jps.10026
El-Sabawi, D. and Hamdan, I.I. (2014) Improvement of Dissolution Rate of Gliclazide through Sodium Salt Formation. Dissolution Technologies, 21, 49-55. https://doi.org/10.14227/DT210414P49
Huuponen, R.K., Viikari, J.S. and Saarima, H. (1984) Correlations of Serum Lipids with Diabetes Control in Sulphonylurea Treated Diabetic Patients. Diabetes Care, 7, 575-578. https://doi.org/10.2337/diacare.7.6.575
Nwanjo, H.U. (2005) Efficacy of Aqueous Leaf Extract of Vernoniaamygdalina on Plasma Lipoprotein and Oxidative Status in Diabetic Rat Models. Nigerian Journal Physiological Science, 20, 39-42.
Dhandapani, S., Ramasamy, S.V., Rajagopal, S. and Namasivayam, N. (2002) Hypolipidemic Effect of Cuninum cyminum L. on Alloxan-Induced Diabetic Rats. Pharmacological Research, 46, 251-255. https://doi.org/10.1016/S1043-6618(02)00131-7
El-Demerdash, F.M., Yousef, M.I. and El-Naga, N.I. (2005) Biochemical Study on the Hypoglycemic Effects of Onion and Garlic in Alloxan Induced Diabetic Rats. Food and Chemical Toxicology, 43, 57-63. https://doi.org/10.1016/j.fct.2004.08.012
Kulkarni, J.S., Metha, A.A., Santani, D.D. and Goyal, R.K. (2002) Effects of Chronic Treatment with Cromakalim and Glibenclamide in Alloxan Induced Diabetic Rats. Pharmacological Research, 46, 101-105. https://doi.org/10.1016/S1043-6618(02)00078-6
Ragavan, B. and Krishnakumari, S. (2006) Antidiabetic Effect of T. ArjunaBark Extract in Alloxan Induced Diabetic Rats. Indian Journal of Clinical Biochemistry, 21, 123-128. https://doi.org/10.1007/BF02912926
Du Vigneaud, V. and Karr, W.G. (1925) Carbohydrate Utilization, Rate of Disappearance of D-glucose from the Blood. Journal of Biological Chemistry, 66, 281-300.
Morton, D.B., Abbot, D., Barclay, R., Close, B.S., Ewbank, R., Gask, D., Heath, M., Mattic, S., Poole, T., Seamer, J. and Southee, J. (1993) Removal of Blood from Laboratory Mammals and Birds. Laboratory Animals, 27, 1-22.
Allain, C.C., Poon, L.S., Chan, C.S., Richmond, W. and Fu, P.C. (1974) Enzymatic Determination of Total Serum Cholesterol. Clinical Chemistry, 20, 470-475.
Footsati, S. and Principe, L. (1982) Serum Triglycerides Determined Colorimetrically with an Enzyme that Produces Hydrogen Peroxide. Clinical Chemistry, 28, 2077-2080.
Bergmenyer, H.U. (1985) Methods of Enzymatic Analysis. 3rd Edition, John Wiley & Sons, New York, 154-160.
Friedewald, V.T., Levy, R.I. and Fredrickson, D.S. (1972) Estimation of Low Density Lipoprotein Cholesterol in Plasma, without Use of Preparative Centrifuge. Clinical Chemistry, 18, 499-502.
Reitman, S. and Frankel, S. (1957) A Colorimetric Method for The Determination of Glutamic Oxaloacetic and Glutamic Pyruvic Transaminases. The American Journal of Clinical Pathology, 28, 56-66. https://doi.org/10.1093/ajcp/28.1.56
Pearlman, F.C. and Lee, R.T. (1974) Detection and Measurement of Total Bilirubin in Serum with Use of Surfactants as Solubilizing Agents. Clinical Chemistry, 20, 447-453.
Henry, R.J., Cannon, D.C. and Winkelman, J.W. (1974) Clinical Chemistry Principles and Techniques. 11th Edition, Happer and Row Publishers, New York, 1629.
Ansel, H.C., Popovich, N.G. and Allen, L.V. (1990) Pharmaceutical Dosage Forms and Drug Delivery Systems. Lea & Febiger, Philadelphia, PA.
Damian, F., Blaton, N., Naesens, L., Balzarini, J., Kinget, R., Augustinjns, P. and Mooter, G.V. (2000) Physicochemical Characterization of Solid Dispersions of the Antiviral Agent UC-781 with Polyethylene Glycol 6000 and Gelucire 44/14. European Journal of Pharmaceutical Sciences, 10, 311-322. https://doi.org/10.1016/S0928-0987(00)00084-1
Shin, S.C. and Kim, J. (2003) Physicochemical Characterization of Solid Dispersion of Furosemide with TPGS. International Journal of Pharmaceutics, 251, 79-84. https://doi.org/10.1016/S0378-5173(02)00586-0
Özkan, Y., Atay, T., Díkman, N., Isimer, A. and Aboul-Enein, Y.H. (2000) Improvement of Water Solubility and in Vitro Dissolution Rate Gliclazide by Complexation with B-Cyclodextrin. Pharmaceutica Acta Helvetiae, 74, 365-370. https://doi.org/10.1016/S0031-6865(99)00063-1
Planinsek, O., Kovacic, B. and Vrecer, F. (2011) Carvedilol Dissolution Improvement by Preparation of Solid Dispersions with Porous Silica. International Journal of Pharmaceutics, 406, 41-48. https://doi.org/10.1016/j.ijpharm.2010.12.035
Valizadeh, H., Nokhodchi, A., Qarakhani, N.P., Zakeri-Milani, S., Azarmi, D.H. and Lobenberg, R. (2004) Physicochemical Characterization of Solid Dispersions of Indomethacin with PEG 6000, Myrj 52, Lactose, Sorbitol, Dextrin, and Eudragit E100. Drug Development and Industrial Pharmacy, 30, 303-317. https://doi.org/10.1081/DDC-120030426
Yin, L.F., et al. (2012) In Vitro and In Vivo Studies on a Novel Solid Dispersion of Repaglinide Using Polyvinylpyrrolidone as the Carrier. Drug Development and Industrial Pharmacy, 38, 1371-1380. https://doi.org/10.3109/03639045.2011.652635
Patel, J.R., et al. (2012) Preparation and Structural Characterization of Amorphous Spray-Dried Dispersions of Tenoxicam with Enhanced Dissolution. Journal of Pharmaceutical Sciences, 101, 641-663. https://doi.org/10.1002/jps.22800
Pahovnik, D., et al. (2011) Determination of the Interaction between Glimepiride and Hyperbranched Polymers in Solid Dispersions. Journal of Pharmaceutical Sciences, 100, 4700-4709. https://doi.org/10.1002/jps.22662
Jackson, J.E. and Bressler, R. (1981) Clinical Pharmacology of Sulphonylurea Hypoglycemic Agents: Part I. Drugs, 22, 211-245. https://doi.org/10.2165/00003495-198122030-00003
Ojo, R.J., Memudu, A.E., Akintayo, C.O. and Akpan, I.S. (2012) Effects of Pre-induction Administration of Allium Sativumon Some Biochemical Parameters in Alloxan Induced Diabetic Rats. Research Journal of Applied Sciences, Engineering and Technology, 4, 5129-5135.
Goodman, L.S. and Gilman, A. (1985) The Pharmacological Basis of Therapeutics. Macmillan, New York, 1490-1510.
Neess, G.C., Zha, Z. and Lopez, D. (1996) Inhibitor of Cholesterol Biosynthesis Increase Hepatic Low Density Lipoprotein Degradation. Archives of Biochemistry and Biophysics, 325, 242-248.
Karuppasamy, B., Antony, N. and Veerabahu, R.M. (2014) Antidiabetic and Antihyperlipidaemic Activity of Ethanol Extract ofMelastomaMalabathricumLinn. Leaf in Alloxan Induced Diabetic Rats. Asian Pacific Journal of Tropical Biomedicine, 4, S442-S448. https://doi.org/10.12980/APJTB.4.2014C122
Navarro, C.M., Montilla, P.M., Martin, A., Jimenez, J. and Utrilla, P.M. (1993) Free Radicals Scavenger and Antihepatotoxic Activity of Rosmarinus. Planta Medica, 59, 312-314. https://doi.org/10.1055/s-2006-959688
Larcan, A.H., Lambert, M.C. and Delorme, N. (1979) Light and Electron Microscopic Study of Hepatic Lesions in the Course of Hyperlactatemia in Diabetic Patients. Diabetes and Metabolism, 5, 103-112.